We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
-14.31%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$127M
AUM Growth
-$27.3M
Cap. Flow
-$1.6M
Cap. Flow %
-1.26%
Top 10 Hldgs %
43.52%
Holding
112
New
3
Increased
9
Reduced
48
Closed
6
Avg Time Held
18.2 quarters
Top 10 Avg Time Held
13.7 quarters
Top 20 Avg Time Held
10.9 quarters

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$540K
2
CYBE
Cyberoptics Corp
CYBE
+$427K
3
OPRX icon
OptimizeRx
OPRX
+$399K
4
IDN icon
Intellicheck
IDN
+$371K
5
TWOU icon
2U Inc
TWOU
+$367K

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Healthcare 22.7%
3 Energy 12.98%
4 Financials 10.58%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
REGN icon
51
Regeneron Pharmaceuticals
REGN
$76.9B
$752K 0.59%
1,272
– –
2021 Q1
5 quarters
RSPG icon
52
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$636M
$724K 0.57%
11,765
-100
-0.8% -$7K
2022 Q1
1 quarter
BLFS icon
53
DELISTED
BioLife Solutions
BLFS
$667K 0.53%
48,315
-300
-0.6% -$4.4K
2019 Q2
12 quarters
ATCX icon
54
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$640K 0.5%
121,745
-650
-0.5% -$6.15K
2021 Q3
3 quarters
PIM icon
55
Franklin Master Intermediate Income Trust
PIM
$145M
$638K 0.5%
187,052
-5,850
-3% -$20.3K
2013 Q4
34 quarters
SHEL icon
56
Shell
SHEL
$285B
$633K 0.5%
12,100
-110
-0.9% -$6.18K
2022 Q1
1 quarter
IBM icon
57
IBM
IBM
$214B
$619K 0.49%
4,385
+2,675
+156% +$361K
2022 Q1
1 quarter
BKI
58
DELISTED
Black Knight, Inc. Common Stock
BKI
$609K 0.48%
9,318
– –
2017 Q4
18 quarters
CNX icon
59
CNX Resources
CNX
$5.03B
$593K 0.47%
36,000
-200
-0.6% -$4.1K
2021 Q1
5 quarters
MESO icon
60
Mesoblast
MESO
$1.86B
$568K 0.45%
127,825
-100
-0.1% -$688
2016 Q3
23 quarters
FAF icon
61
First American
FAF
$6.25B
$548K 0.43%
10,350
– –
2013 Q4
34 quarters
CVE icon
62
Cenovus Energy
CVE
$57.9B
$547K 0.43%
28,800
– –
2022 Q1
1 quarter
NVS icon
63
Novartis
NVS
$273B
$546K 0.43%
6,460
– –
2013 Q4
34 quarters
IMMR icon
64
Immersion
IMMR
$247M
$531K 0.42%
99,420
-37,600
-27% -$195K
2019 Q1
13 quarters
IMDX icon
65
Insight Molecular Diagnostics
IMDX
$110M
$518K 0.41%
28,788
-120
-0.4% -$2.73K
2019 Q4
10 quarters
XGN icon
66
Exagen
XGN
$204M
$506K 0.4%
88,100
-500
-0.6% -$2.91K
2021 Q3
3 quarters
IBB icon
67
iShares Biotechnology ETF
IBB
$10.9B
$483K 0.38%
4,110
-60
-1% -$7.12K
2016 Q2
24 quarters
BDX icon
68
Becton Dickinson
BDX
$50.1B
$473K 0.37%
1,920
-58
-3% -$14.7K
2013 Q4
34 quarters
RSP icon
69
Invesco S&P 500 Equal Weight ETF
RSP
$97.5B
$464K 0.37%
3,460
– –
2017 Q4
18 quarters
EMR icon
70
Emerson Electric
EMR
$90.3B
$461K 0.36%
5,800
– –
2014 Q1
33 quarters
CHGG icon
71
Chegg
CHGG
$81.7M
$432K 0.34%
23,015
-100
-0.4% -$2.29K
2014 Q2
32 quarters
EGIO icon
72
DELISTED
Edgio, Inc. Common Stock
EGIO
$415K 0.33%
+4,494
New +$647K
2022 Q2
0 quarters
FISV icon
73
Fiserv Inc
FISV
$24.3B
$408K 0.32%
4,591
– –
2013 Q4
34 quarters
BBSI icon
74
Barrett Business Services
BBSI
$769M
$401K 0.32%
22,000
-800
-4% -$14.7K
2015 Q4
26 quarters
LINC icon
75
Lincoln Educational Services
LINC
$745M
$393K 0.31%
62,305
-500
-0.8% -$3.14K
2022 Q1
1 quarter

Similar funds

Penbrook Management's Q2 2022 Portfolio in Review

As of Q2 2022, Penbrook Management held 112 positions worth $127M, down 18% from $154M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Penbrook Management's Q2 2022 filing shows 3 new, 9 increased, 48 reduced and 6 closed positions. Its largest new stake was Edgio, Inc. Common Stock: 4,494 shares worth $415K. The largest sale was Microsoft, an estimated $540K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

  • Penbrook Management's largest Q2 2022 buy was Edgio, Inc. Common Stock: 4,494 shares worth $415K.
  • Penbrook Management added most to IBM in Q2 2022, an estimated $361K increase.
  • Penbrook Management's biggest Q2 2022 reduction was Microsoft, cutting an estimated $540K.
  • Penbrook Management fully exited OptimizeRx in Q2 2022, selling an estimated $399K.
  • Penbrook Management's ten largest holdings make up 44% of its $127M portfolio in Q2 2022.
  • Penbrook Management opened 3 new positions and closed 6 in Q2 2022.
  • Penbrook Management's portfolio value fell 18% quarter-over-quarter to $127M.

Based on Penbrook Management's 13F filing for Q2 2022, filed 29 Jul 2022.